Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nextcure Inc
(NQ:
NXTC
)
1.610
+0.030 (+1.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nextcure Inc
< Previous
1
2
3
Next >
A Phase 2 Study of Anti-Siglec-15 Antibody, NC318, in Combination with Pembrolizumab (NCT04699123) Demonstrates Clinical Activity in Patients with Advanced PD-1 Axis Inhibitor Refractory NSCLC
September 12, 2023
From
NextCure
Via
GlobeNewswire
NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
September 07, 2023
From
NextCure
Via
GlobeNewswire
Preclinical Data Demonstrate Potential Application of Anti-Siglec-15 Treatment in Bone Disease
September 05, 2023
From
NextCure
Via
GlobeNewswire
NextCure, LegoChem Biosciences Ink Collaborative Pact For Antibody Drug Conjugates
November 16, 2022
Via
Benzinga
NextCure: Q4 Earnings Insights
March 04, 2022
NextCure (NASDAQ:NXTC) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
NextCure to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 31, 2023
From
NextCure
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
NextCure Provides Business Update and Reports Second Quarter 2023 Financial Results
August 03, 2023
From
NextCure
Via
GlobeNewswire
NextCure Presents Non-Clinical Data Defining the Mechanism of NC525 at the 2023 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
June 21, 2023
From
NextCure
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 13, 2023
Via
Benzinga
NextCure to Present at the JMP Securities Life Sciences Conference
May 09, 2023
From
NextCure
Via
GlobeNewswire
NextCure Provides Business Update and Reports First Quarter 2023 Financial Results
May 04, 2023
From
NextCure
Via
GlobeNewswire
NextCure to Present at 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
NextCure
Via
GlobeNewswire
NextCure Provides Business Update and Reports Full Year 2022 Financial Results
March 02, 2023
From
NextCure
Via
GlobeNewswire
NextCure to Present at SVB Securities Global Biopharma Conference
February 07, 2023
From
NextCure
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
November 29, 2022
On Tuesday, 89 companies set new 52-week lows.
Via
Benzinga
NextCure to Present at Upcoming Investor Conferences
November 22, 2022
From
NextCure
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
On Monday, 79 companies reached new 52-week lows.
Via
Benzinga
NextCure and LegoChem Biosciences Enter into Collaboration and Co-Development Agreement to Develop Antibody Drug Conjugates
November 15, 2022
From
NextCure
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
November 10, 2022
During Thursday's session, 97 companies made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 07, 2022
Gainers
Via
Benzinga
NextCure Presents Initial Data from Clinical Trial of NC762 and a Trial in Progress Poster for NC410 Combo at the 2022 Society for Immunotherapy of Cancer Annual Meeting
November 07, 2022
From
NextCure
Via
GlobeNewswire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 04, 2022
Friday's session saw 236 companies set new 52-week lows.
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
NextCure Provides Update and Reports Third Quarter 2022 Financial Results
November 03, 2022
From
NextCure
Via
GlobeNewswire
NextCure to Present Trial in Progress Poster for NC525 at the 2022 American Society of Hematology (ASH) Annual Meeting
November 03, 2022
From
NextCure
Via
GlobeNewswire
NextCure Appoints Dr. Lisa M. Coussens to Scientific Advisory Board
October 27, 2022
From
NextCure
Via
GlobeNewswire
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
October 05, 2022
From
NextCure
Via
GlobeNewswire
NextCure Announces Initiation of Phase 1b/2 Clinical Trial to Evaluate NC410 in Combination with KEYTRUDA® (Pembrolizumab) in Patients with Immune Checkpoint Refractory or Naïve Solid Tumors
October 04, 2022
From
NextCure
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.